Literature DB >> 27436480

Ghrelin attenuates hyperalgesia and light aversion-induced by nitroglycerin in male rats.

Fereshteh Farajdokht1, Shirin Babri1, Pouran Karimi1, Gisou Mohaddes2.   

Abstract

Systemic administration of nitroglycerin (NTG) consistently provokes spontaneous-like migraine attacks in migraine sufferers, and in rat it induces hyperalgesia and allodynia. In the present study we modeled migraine headache by intraperitoneal (i.p.) injection of a single dose of NTG, which produced widespread thermal allodynia and mechanical hyperalgesia, photophobia, and increased anxiety-like behaviors and serum concentration of cortisol. Results suggest that the effects of NTG can be largely reversed by administration of ghrelin, which mimics the effects of sumatriptan used as relevant positive therapeutic control in this study. These findings suggest that ghrelin may alleviate some of the negative emotional states associated with migraine and may hold therapeutic potential in treating migraine headache.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cortisol; Ghrelin; Hyperalgesia; Light aversion; Nitroglycerin

Mesh:

Substances:

Year:  2016        PMID: 27436480     DOI: 10.1016/j.neulet.2016.07.026

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Targeted Nitric Oxide Synthase Inhibitors for Migraine.

Authors:  Amynah A Pradhan; Zachariah Bertels; Simon Akerman
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

2.  Investigating Migraine-Like Behavior Using Light Aversion in Mice.

Authors:  Mengya Wang; Bianca N Mason; Levi P Sowers; Adisa Kuburas; Brandon J Rea; Andrew F Russo
Journal:  J Vis Exp       Date:  2021-08-11       Impact factor: 1.424

3.  Animal Model of Chronic Migraine-Associated Pain.

Authors:  Laura S Moye; Amynah A A Pradhan
Journal:  Curr Protoc Neurosci       Date:  2017-07-05

4.  Ghrelin Exerts Analgesic Effects through Modulation of IL-10 and TGF-β Levels in a Rat Model of Inflammatory Pain.

Authors:  Faranak Azizzadeh; Javad Mahmoodi; Saeed Sadigh-Eteghad; Fereshteh Farajdokht; Gisou Mohaddes
Journal:  Iran Biomed J       Date:  2016-10-05

5.  The Effectiveness of Scutellaria baicalensis on Migraine: Implications from Clinical Use and Experimental Proof.

Authors:  Chung-Chih Liao; Ke-Ru Liao; Cheng-Li Lin; Jung-Miao Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-06       Impact factor: 2.629

Review 6.  Could Experimental Inflammation Provide Better Understanding of Migraines?

Authors:  Philip Victor Reducha; Lars Edvinsson; Kristian Agmund Haanes
Journal:  Cells       Date:  2022-08-06       Impact factor: 7.666

7.  Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization.

Authors:  Lorenz S Neuwirth; Michael T Verrengia; Zachary I Harikinish-Murrary; Jessica E Orens; Oscar E Lopez
Journal:  Front Mol Neurosci       Date:  2022-08-17       Impact factor: 6.261

Review 8.  The neurobiology of pain and facial movements in rodents: Clinical applications and current research.

Authors:  Adriana Domínguez-Oliva; Daniel Mota-Rojas; Ismael Hernández-Avalos; Patricia Mora-Medina; Adriana Olmos-Hernández; Antonio Verduzco-Mendoza; Alejandro Casas-Alvarado; Alexandra L Whittaker
Journal:  Front Vet Sci       Date:  2022-09-29

9.  Exacerbated Headache-Related Pain in the Single Prolonged Stress Preclinical Model of Post-traumatic Stress Disorder.

Authors:  Yong Zhang; Kelly M Standifer
Journal:  Cell Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.046

10.  A Pre-Existing Myogenic Temporomandibular Disorder Increases Trigeminal Calcitonin Gene-Related Peptide and Enhances Nitroglycerin-Induced Hypersensitivity in Mice.

Authors:  Hui Shu; Sufang Liu; Yuanyuan Tang; Brian L Schmidt; John C Dolan; Larry L Bellinger; Phillip R Kramer; Steven D Bender; Feng Tao
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.